Dr. Armstrong Discusses Findings of ARCHES Trial in Prostate Cancer OncLive 1:38 5 years ago 199 Далее Скачать
Andrew Armstrong, MD, presents an overview of the ARCHES trial in mHSPC OBRoncology 2:07 5 years ago 66 Далее Скачать
Update on ARCHES trial: implications for prostate cancer treatment VJOncology 3:57 5 years ago 369 Далее Скачать
ARCHES trial: androgen deprivation therapy with enzalutamide or placebo in mHSPC ecancer 3:43 5 years ago 310 Далее Скачать
ASCO GU 2019 - Dr. Andrew J. Armstrong, Duke University, NC, USA Oncology Information Group 2:29 5 years ago 138 Далее Скачать
Dr. Armstrong on the Utility of Pamiparib and Other PARP Inhibitors in Prostate Cancer OncLive 1:00 4 years ago 196 Далее Скачать
Andrew Armstrong, MD, discusses the Phase 2 STREAM study in pre-metastatic prostate cancer OBRoncology 1:18 5 years ago 23 Далее Скачать
Andrew Armstrong, MD, on determining treatment of prostate cancer with DNA repair markers OBRoncology 2:09 4 years ago 122 Далее Скачать
Dr. Andrew Armstrong on Precision Medicine Approaches in Advanced Prostate Cancer DocWire 9:53 3 years ago 102 Далее Скачать
Andrew Armstrong, MD, explains whether ARV-7 is predictive of response to taxanes in mPC patients OBRoncology 1:05 4 years ago 40 Далее Скачать
Dr. Armstrong on Precision Medicine for Metastatic Prostate Cancer OncLive 1:14 7 years ago 197 Далее Скачать
Future developments in the treatment of prostate cancer VJOncology 1:41 2 years ago 389 Далее Скачать
